Related Experiment Videos
Low-grade gliomas in adults
1Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, UK. j.rees@ion.ucl.ac.uk
Current Opinion in Neurology
|November 26, 2002
Summary
Management of adult supratentorial low-grade gliomas remains controversial. Advances in molecular genetics and imaging improve prognostication and understanding of tumor behavior, though optimal treatment strategies are still evolving.
Area of Science:
- Neuro-oncology
- Neurosurgery
- Radiation Oncology
Background:
- Adult supratentorial low-grade gliomas are well-differentiated primary brain tumors common in young adults.
- These tumors exhibit slow growth, infiltrate brain tissue, and have a propensity for malignant transformation.
- The optimal management and timing of interventions for these tumors are subjects of ongoing debate.
Purpose of the Study:
- To review current understanding and management strategies for adult supratentorial low-grade gliomas.
- To discuss the roles and controversies surrounding surgical and radiotherapeutic interventions.
- To highlight the impact of emerging imaging and molecular techniques.
Main Methods:
- Literature review and synthesis of current evidence on low-grade glioma management.
- Analysis of the efficacy and limitations of surgical resection and radiotherapy.
- Evaluation of the role of molecular markers (e.g., 1p/19q allelic loss) and advanced imaging.
Main Results:
- Evidence supporting the correlation between extent of surgical resection and survival is limited.
- Radiotherapy improves progression-free survival but not overall survival and may cause cognitive deficits.
- Chemosensitivity is observed in a subset of oligodendroglial tumors, linked to 1p/19q allelic loss.
- New imaging and molecular techniques offer insights but have not yet significantly altered clinical practice.
Conclusions:
- The optimal management strategy for low-grade gliomas is not yet definitively established.
- Molecular genetics and advanced imaging are enhancing prognostication and the understanding of tumor natural history.
- Continued research is crucial for refining treatment approaches and improving patient outcomes.